180 related articles for article (PubMed ID: 6181407)
21. Development of monoclonal antibodies to the human breast carcinoma cell line PMC42.
Dempsey PJ; Feleppa FP; Brown RW; de Kretser TA; Whitehead RH; Jose DG
J Natl Cancer Inst; 1986 Jul; 77(1):1-15. PubMed ID: 2425115
[TBL] [Abstract][Full Text] [Related]
22. Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines.
Giacomini P; Giorda E; Fraioli R; Nicotra MR; Vitale N; Setini A; Delfino L; Morabito A; Benevolo M; Venturo I; Mottolese M; Ferrara GB; Natali PG
Cancer Res; 1999 Jun; 59(11):2657-67. PubMed ID: 10363989
[TBL] [Abstract][Full Text] [Related]
23. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
Concha A; Esteban F; Cabrera T; Ruiz-Cabello F; Garrido F
Semin Cancer Biol; 1991 Feb; 2(1):47-54. PubMed ID: 1912518
[TBL] [Abstract][Full Text] [Related]
24. The expression of HLA on two cultured choriocarcinoma cell lines.
Tanimoto M; Takahashi T; Nishizuka Y
Gan; 1982 Feb; 73(1):27-34. PubMed ID: 6956527
[TBL] [Abstract][Full Text] [Related]
25. Conformation and surface expression of free HLA-CW1 heavy chains in the absence of beta 2-microglobulin.
Martayan A; Fiscella M; Setini A; Ciccarelli G; Gambari R; Feriotto G; Beretta A; Siccardi AG; Appella E; Giacomini P
Hum Immunol; 1997 Mar; 53(1):23-33. PubMed ID: 9127144
[TBL] [Abstract][Full Text] [Related]
26. Expression of surface antigens during the cell cycle in different growth phases of American and African Burkitt's lymphoma cell lines.
Sieverts H; Alabaster O; Goldschmidts W; Magrath I
Cancer Res; 1986 Mar; 46(3):1182-8. PubMed ID: 3080238
[TBL] [Abstract][Full Text] [Related]
27. Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer.
Bhan AK; DesMarais CL
J Natl Cancer Inst; 1983 Sep; 71(3):507-16. PubMed ID: 6193308
[TBL] [Abstract][Full Text] [Related]
28. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast.
Zuk JA; Walker RA
J Pathol; 1987 Aug; 152(4):275-85. PubMed ID: 3312546
[TBL] [Abstract][Full Text] [Related]
30. Cell surface antigens of human trophoblast and choriocarcinoma defined by monoclonal antibodies.
Rettig WJ; Cordon-Cardo C; Koulos JP; Lewis JL; Oettgen HF; Old LJ
Int J Cancer; 1985 Apr; 35(4):469-75. PubMed ID: 2580800
[TBL] [Abstract][Full Text] [Related]
31. HLA-A,B antigens Ia-like antigens, and tumor-associated antigens on prostate carcinoma cell lines: serologic and immunochemical analysis with monoclonal antibodies.
Ng AK; Pellegrino MA; Imai K; Ferrone S
J Immunol; 1981 Aug; 127(2):443-7. PubMed ID: 6788840
[TBL] [Abstract][Full Text] [Related]
32. Surface expression of HLA-C antigen by human extravillous trophoblast.
King A; Burrows TD; Hiby SE; Bowen JM; Joseph S; Verma S; Lim PB; Gardner L; Le Bouteiller P; Ziegler A; Uchanska-Ziegler B; Loke YW
Placenta; 2000 May; 21(4):376-87. PubMed ID: 10833373
[TBL] [Abstract][Full Text] [Related]
33. Serological analysis of cell surface antigens in choriocarcinoma cell lines.
Saito M; Goto S; Kato S; Okamoto T; Tomoda Y
Am J Reprod Immunol; 1989 Mar; 19(3):114-9. PubMed ID: 2765138
[TBL] [Abstract][Full Text] [Related]
34. Two distinct antigen systems in human B lymphocytes: identification of cell surface and intracellular antigens using monoclonal antibodies.
Ishii Y; Takami T; Yuasa H; Takei T; Kikuchi K
Clin Exp Immunol; 1984 Oct; 58(1):183-92. PubMed ID: 6332692
[TBL] [Abstract][Full Text] [Related]
35. Class 1 major histocompatibility complex antigens on human extra-villous trophoblast.
Redman CW; McMichael AJ; Stirrat GM; Sunderland CA; Ting A
Immunology; 1984 Jul; 52(3):457-68. PubMed ID: 6204930
[TBL] [Abstract][Full Text] [Related]
36. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
[TBL] [Abstract][Full Text] [Related]
37. Differential effect of human and mouse beta 2-microglobulin on the induction and the antigenic profile of endogenous HLA-A and -B antigens synthesized by beta 2-microglobulin gene-null FO-1 melanoma cells.
Wang Z; Hu XZ; Tatake RJ; Yang SY; Zeff RA; Ferrone S
Cancer Res; 1993 Sep; 53(18):4303-9. PubMed ID: 7689931
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibodies (F36/22 and M7/105) to human breast carcinoma.
Papsidero LD; Croghan GA; O'Connell MJ; Valenzuela LA; Nemoto T; Chu TM
Cancer Res; 1983 Apr; 43(4):1741-7. PubMed ID: 6339043
[TBL] [Abstract][Full Text] [Related]
39. [Immunobiology of vesicular mole and choriocarcinoma].
Mangili G; Illeni MT; Spolti N; Lombardo C; Bruno L; Maggi R
Ann Ostet Ginecol Med Perinat; 1990; 111(5):326-31. PubMed ID: 2092608
[TBL] [Abstract][Full Text] [Related]
40. [Effect of interferon on human cell lines which do not express class I transplantation antigens: K 562 and Daudi. Presence of a pseudo-messenger RNA of beta 2-microglobulin in Daudi cell line].
Rosa F; Fellous M
C R Seances Acad Sci III; 1982 Oct; 295(5):359-64. PubMed ID: 6185189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
